BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
NEUROG3
,
T cell receptor signaling pathway
,
Hepatitis
,
Leukocyte
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
carcinoma liver
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Malignant neoplasms
GSK cancer cell line transcript profiling
Cancer Gene Census - mutations in cancer genes
OMIM - Cancer
Tumor and paired adjacent normal tissues of patients with 9 different cancer types
Explore Curated Studies Results
Literature
Most Relevant Literature
Status Quo and Development of Immunotherapy for Hepatocellular Carcinoma].
Immunotherapy for hepatocellular carcinoma.
Hepatocellular Carcinoma: The Role of MicroRNAs.
Imaging in Hepatocellular Carcinoma: What's New?
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver
Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ